Many cancer cells contain more than two centrosomes, which imposes a potential for multipolar mitoses, leading to cell death. To circumvent this, cancer cells develop mechanisms to cluster supernumerary centrosomes to form bipolar spindles, enabling successful mitosis. Disruption of centrosome clustering thus provides a selective means of killing supernumerary centrosome-harboring cancer cells. Although the mechanisms of centrosome clustering are poorly understood, recent genetic analyses have identified requirements for both actin and tubulin regulating proteins. In this study, we demonstrate that the integrin-linked kinase (ILK), a protein critically involved in actin and mitotic microtubule organization, is required for centrosome clustering. Inhibition of ILK expression or activity inhibits centrosome clustering in several breast and prostate cancer cell lines that have centrosome amplification. Furthermore, cancer cells with supernumerary centrosomes are significantly more sensitive to ILK inhibition than cells with two centrosomes, demonstrating that inhibiting ILK offers a selective means of targeting cancer cells. Live cell analysis shows ILK perturbation leads cancer cells to undergo multipolar anaphases, mitotic arrest and cell death in mitosis. We also show that ILK performs its centrosome clustering activity in a focal adhesion-independent, but centrosome-dependent, manner through the microtubule regulating proteins TACC3 and ch-TOG. In addition, we identify a specific TACC3 phosphorylation site that is required for centrosome clustering and demonstrate that ILK regulates this phosphorylation in an Aurora-A-dependent manner.
Introduction
Supernumerary centrosomes, a state in which cells contain more than two centrosomes, are a common characteristic of human cancer cells. Supernumerary centrosomes were first observed in cancer cells nearly 100 years ago (Boveri, 1914) and have now been reported in many malignancies in vivo, including bladder, brain, breast, bile duct, cervical, colon, head and neck, liver, lung, ovarian, pancreas and prostate tumors, as well as myeloma, lymphomas and leukemias (Lingle and Salisbury, 1999; Kramer et al., 2002; Nigg, 2002; Pihan et al., 2003; Zyss and Gergely, 2009) . Although supernumerary centrosomes can potentially facilitate tumorigenesis by disrupting cellular polarity (Nigg, 2006; Basto et al., 2008) and increasing the likelihood of aneuploidy (Lingle et al., 2002; Ganem et al., 2009; Silkworth et al., 2009) , they also impose a potential for multipolar mitoses leading to cell death (Brinkley, 2001; Nigg, 2002; Ganem et al., 2009) . To circumvent this, many cancer cells develop mechanisms to cluster supernumerary centrosomes to form bipolar spindles and hence, ensure bipolar mitosis and cell survival (Ring et al., 1982; Brinkley, 2001; Quintyne et al., 2005; Rebacz et al., 2007; Kwon et al., 2008) . Disruption of centrosome clustering and induction of multipolar spindle formation thus provides a selective means of killing supernumerary centrosome-harboring cancer cells (Kwon et al., 2008; Xu and Saunders, 2008) .
Although details remain poorly understood, recent genetic analyses have identified three broad, overlapping mechanisms that regulate centrosome clustering (Kwon et al., 2008) . First, several microtubule-interacting/ regulating genes were identified, including Ncd (human spleen, embryo, testes protein (HSET)) and D-TACC (Kwon et al., 2008) . D-TACC, a protein involved in stabilizing the minus and plus ends of microtubules at centrosomes in concert with the microtubule-associated protein ch-TOG/XMAP-215/CKAP5 (Lee et al., 2001; Barros et al., 2005) , was not investigated further in this report.
The second broad group of genes identified to be required for the prevention of multipolar mitoses were those involved either directly in actin cytoskeleton organization, or those which contribute to interphase cell shape by linking the extra-cellular-matrix to the actin cytoskeleton.
Integrin-linked kinase (ILK) localizes to focal adhesions and is critically involved in both actin and cell adhesion regulation (for reviews see Legate et al., 2006; McDonald et al., 2008) . Moreover, several reports demonstrate that ILK has a role in mitosis by regulation of the microtubule cytoskeleton. Mitotic defects have been detected upon ILK depletion in Drosophila S2 cells (Bettencourt-Dias et al., 2004) , mouse hepatocytes (Gkretsi et al., 2007) and human glioblastoma cells (Koul et al., 2005; Edwards et al., 2008) . It is interesting that, although the cellular phenotypes were not reported in detail in these studies, all of these systems contain supernumerary centrosomes (Weber et al., 1998; Guidotti et al., 2003; Margall-Ducos et al., 2007; Kwon et al., 2008) . ILK has also been shown to localize to centrosomes and regulate mitotic microtubule organization, likely through its influences on Aurora-A/ch-TOG/ TACC3 complex formation . It is interesting that the ILK-interacting proteins at both focal adhesions (Mig-2 (Tu et al., 2003) ) and the centrosomes (TACC3 ) have been implicated in centrosome clustering (Kwon et al., 2008) and ILK itself has been suggested as a candidate for regulating this process (Xu and Saunders, 2008) . Therefore, we sought to test whether ILK is required for centrosome clustering and if so whether inhibiting ILK can selectively inhibit the growth of cancer cells.
In this study, we demonstrate that ILK is required for centrosome clustering, and inhibiting ILK expression with small interfering RNA (siRNA) or activity with a small molecule inhibitor, induces multipolar spindles in several breast and prostate cancer cell lines that have centrosome amplification. Furthermore, cancer cells with supernumerary centrosomes are more sensitive to ILK inhibition than cells with two centrosomes and show defects in cell division resulting in decreased cell proliferation. We also found that the centrosomal proteins TACC3 and ch-TOG, which co-localize, interact with and are regulated by ILK Fielding et al., 2008) are required for centrosome clustering in mammalian cells, whereas key focal adhesion binding partners of ILK are not. ILK performs its centrosome-clustering functions independently of the actin cytoskeleton and by its centrosomal, microtubule-regulating partner TACC3. In addition, we show that a specific TACC3 phosphorylation event is required for centrosome clustering and that this is regulated by ILK, in an Aurora-A-dependent manner.
Results
ILK knockdown prevents centrosome clustering in breast and prostate cancer cell lines BT549 and MDA-MB-231 breast cancer cell lines have high percentages of cells harboring greater than two centrosomes (45 and 44%, respectively (Kwon et al., 2008) , see Supplementary Table 1 for further details). Following control or ILK siRNA transfection these cells were processed for immunofluorescence and stained for markers of microtubules, centrosomes and DNA to enable the analysis of multipolar spindle formation. The resulting phenotypes were scored as illustrated in Figure 1a and the percentage of 'de-clustered' centrosomes calculated for each treatment. Approximately 10% of control-treated BT549s contained de-clustered centrosomes and multipolar spindles. This is in accordance with data from Kwon et al, who reported 14% of control-treated BT549 cells showed multipolar spindles (Kwon et al., 2008) . However, ILK siRNA treatment resulted in greater than 36% of the cells displaying declustered centrosomes (Figures 1a and c) . A similar pattern was observed in MDA-MB-231 cells and also, as an example of a different cancer type, prostate-derived PC3 cells (Figures 1b and c) . These results imply that ILK participates in the clustering of supernumerary centrosomes in both breast and prostate cancer cells. These experiments were performed using pericentrin to stain for centrosomes because of the availability of a highly specific antibody against this protein. However, because of the potential difficulties of distinguishing between true centriole-containing centrosomes and other sites of microtubule nucleation that may recruit components of the soluble pericentriolar-material, such as pericentrin, multipolar spindles induced by ILK perturbation were also examined with an antibody against centrin 2, one of the core structural components of centrioles. This indicated that nearly all spindle poles examined in ILK-depleted cells were due to the presence of true centrosomes as each stained for a pair of centrin 2 foci (Supplementary Figure 1) . Quantification of the percentage of de-clustered centrosomes in ILK-depleted cells as judged by centrin 2 staining gave very similar results to the pericentrin quantifications (Supplementary Figure 1c) .
Next, we sought to determine whether inhibiting ILK kinase activity using a pharmacological ILK inhibitor could also prevent centrosome clustering and whether this effect was specific to cancer cells.
Pharmacological inhibition of ILK leads to multipolar spindle formation in breast and prostate cancer but not normal epithelial cells For analysis of the effects of the small-molecule inhibitor of ILK kinase activity, QLT-0267 (characterized in Troussard et al., 2006) , the panel of breast cells lines was expanded to include a breast cancer cell line that has a low percentage of supernumerary centrosome-harboring cells (MCF7 (Kwon et al., 2008) ) and two normal breast epithelial cell lines, which contain a very low percentage of cells with greater than two centrosomes, MCF10As (You et al., 2004) and 184-hTERTs (our own, unpublished data. See Supplementary Table 1 for additional information).
A range of QLT-0267 concentrations were added for 6 h and the percentage of cells displaying de-clustered centrosomes calculated. BT549 and MDA-231 cells show a dose-dependent increase in mitoses containing de-clustered centrosomes, whereas the cell lines containing relatively low percentages of cells with supernumerary centrosomes do not (Figure 2a ). It has previously been shown that QLT-0267 inhibits ILK kinase activity with a half maximal inhibitory concentration (IC50) of between 2-5 mM, depending on cell type (Troussard et al., 2006) . This correlates well with the effect on centrosome clustering observed here, suggesting that ILK kinase activity is likely to be the driving force behind the phenotypes observed. QLT-0267 was also added to non-cancerous (BPH-1) and cancerous (PC3) prostate cell lines. Reflecting the results obtained with the breast cell lines, the inhibitor-induced centrosome de-clustering in the PC3, but not the BPH-1 cells (Figure 2d ).
These results imply that ILK inhibition perturbs the ability of cells to cluster supernumerary centrosomes yet, it is important that, does not itself induce the formation of supernumerary centrosomes. This also suggests that inhibiting ILK may have deleterious effects on supernumerary centrosome-containing cancer cells, although leaving cells with a normal centrosome complement unperturbed. This theory was tested next.
Centrosome number correlates with sensitivity to ILK inhibition in panel of breast and prostate cell lines Clonogenic assays were performed on the panel of breast cell lines to determine their sensitivity to the ILK inhibitor. It was found that there was a highly significant difference between the normal cell types with two centrosomes, which were unaffected by 2.5 mM QLT-0267, and the supernumerary centrosome-containing BT549 and MDA-MB-231 cancer cells, where the surviving fraction of cells at 2.5 mM QLT-0267 was less than 10% (Figures 2b and c) . These results were reflected in the survival of the prostate cell lines, with the non-cancerous BPH-1 cells being only minimally effected whereas the proliferation of the cancerous PC3 cells was significantly reduced (Figure 2e ).
These data present strong correlative evidence that the centrosome de-clustering activity observed upon ILK inhibition leads to decreased proliferation of cancer cells. However, it is known that ILK inhibition can lead to cancer cell-specific decreases in cell-survival signaling, such as decreased v-akt murine thymoma viral oncogene homolog 1 (AKT 473 ) phosphorylation (Troussard et al., 2006) that may partially account for the decrease in cell survival observed in the cancer cell lines. It could not, however, explain the difference seen between the cancer cell lines with high (BT549s and MDA-MB-231) and low (MCF7) percentages of supernumerary centrosomes. Despite this, to test whether the decreased proliferation observed in the clonogenic assays was due, at least in part, to mitosis-related events, we performed time-lapse imaging to determine the mitotic outcomes of cells in which ILK was inhibited.
ILK inhibition leads to multipolar anaphases and cytokinesis, prolonged mitotic arrest and cell death in mitosis MDA-MB-231 cells were treated with either dimethyl sulfoxide (DMSO) or QLT-0267 and observed by phase microscopy and the fate of all cells attempting mitosis was categorized into six groups ( Figure 3a ). It is of note that, only 21.3% of QLT-0267-treated cells underwent successful bipolar divisions (category 1, Figure 3c ) as opposed to 66.7% of DMSO-treated cells. This difference was mostly accounted for by three categories seen with increased frequency in the ILK-inhibited cells. These were cells that enter mitosis, but do not proceed to anaphase and, after prolonged arrest, exit mitosis (category 2 and Figure 3d ), cells that had been arrested in mitosis for 4120 min at the end of the time course (category 5) and cells that became arrested in mitosis and subsequently underwent cell death (category 6 and Figure 3f ). As prolonged mitoses seemed to be a feature of the ILK-inhibited cells, the length of mitosis (from nuclear envelope breakdown to the onset of anaphase) was calculated for each cell where this was possible and these data were plotted in Figure 3b . This analysis confirmed that the ILK-inhibited cells did indeed spend significantly more time in mitosis.
The percentage of cells that failed in the final stages of cytokinesis and underwent furrow regression to form a bi-nucleated progeny (category 3) was higher than initially expected in control-treated cells (31.0%), although was further elevated upon QLT-0267 treatment (37.7%). It is possible that this high rate of cytokinesis failure in the control cells may be due to the phototoxicity of the imaging regime. However, these results may at least in part be explained by observations that cells with supernumerary centrosomes often pass through multipolar anaphase intermediates that can leave chromosomes stranded near the center of the cell, referred to as lagging chromosomes (Ganem et al., 2009; Silkworth et al., 2009) , the presence of which correlates with cytokinesis failure (Silkworth et al., 2009) . Indeed, MDA-MB-231 cells that contain multiple centrosomes have a high rate of lagging chromosomes even in cells undergoing normal bipolar anaphases (Ganem et al., 2009) , which could account for the high rate of cytokinesis failure in control-treated cells.
Detailed analysis of the movies revealed that 23.0% of QLT-0267-treated cells showed multipolar anaphase and cytokinesis intermediates, as compared with just 1.2% in controls, indicative of centrosome de-clustering. However, the majority of these multipolar intermediates did not go on to complete multipolar cytokineses, resulting in only 3.3% of QLT-0267-treated (and 0.0% of DMSO-treated) cells (category 4, Figure 3e ) actually completing multipolar cell divisions. This notwithstanding, cells that displayed multipolar anaphase/cytokinesis intermediates rarely underwent successful bipolar divisions, instead often undergoing cytokinesis failure to produce multinuclear progeny (Supplementary Figure 2a) or uneven bipolar divisions where one cell was considerably smaller than the other (Supplementary Figure 2b) .
To complement this data, the mitotic index of both MDA-MB-231 cells and the non-cancerous MCF10A cells was calculated subsequent to treatment with the ILK inhibitor (Supplementary Figure 4) . MDA-MB-231 cells showed an increase in mitotic index upon ILK inhibition, reflective of the live-cell analysis showing the induction of mitotic arrest, whereas the MCF10A cells showed no such increase. This supports the data presented in Figure 2 that the mitotic dynamics and proliferation of normal cells, the majority of which contain the normal number of centrosomes, is not affected by ILK perturbation.
In summary, these data indicate that ILK inhibition does indeed cause adverse outcomes for cancer cells attempting mitosis that will result in decreased cell proliferation. Next, we investigated the mechanism by which ILK influences centrosome clustering.
ILK's centrosomal partners, TACC3 and ch-TOG, regulate centrosome clustering in human cancer cells Both actin-cytoskeleton regulating and microtubuleorganizing proteins are required for centrosome clustering (Kwon et al., 2008) . ILK regulates the actin cytoskeleton from its location at focal adhesions (for reviews see Legate et al., 2006; McDonald et al., 2008) and microtubule organization through centrosomalinteracting partners (Bettencourt-Dias et al., 2004; Dobreva et al., 2008; Fielding et al., 2008) . Therefore, to begin to elucidate the mechanism by which ILK effects centrosome clustering we first tested whether any of ILK's known centrosomal or focal-adhesion-interacting partners also influenced multipolar spindle formation.
Ch-TOG and TACC3 co-localize, interact with and are influenced by ILK Fielding et al., 2008) and are also key regulators of microtubule dynamics (Lee et al., 2001; Gergely et al., 2003; Barros et al., 2005) . Figure 4 shows that both TACC3 and ch-TOG depletion lead to significant increases in declustered centrosomes in both BT549 and PC3 cells. TACC3 siRNA lead to increases in de-clustered centrosomes on a similar scale to ILK. However, ch-TOG siRNA lead to much greater increases in the appearance of multipolar spindles in both cell lines (Figure 4b ). This agrees with the report that ch-TOG depletion can induce the formation of multipolar spindles by two pathways, centrosome de-clustering and also the formation of acentrosomal spindle poles (Barr and Gergely, 2008 ). This in turn suggests that TACC3 and ILK are only involved in one of these pathways. Supplementary  Figure 1 shows that nearly all ILK and TACC3 siRNA-induced multipolar spindles stained for a pair of centrin 2 foci at each of the spindle poles present, whereas a significant proportion of ch-TOG siRNAtreated cells contained spindle poles that did not stain for centrin 2. Acentrosomal poles, however, did not account for all multipolar spindles observed with the remainder of the multipolar spindles observed because of the centrosome de-clustering (Supplementary Figure  1c) . This confirms the role of ch-TOG in both the formation of acentrosomal spindle poles and centrosome clustering. Therefore, two of ILK's centrosomal-interacting partners are required for centrosome clustering. We also assessed whether ILK's key binding partners at focal adhesions are required for centrosome clustering and whether ILK's effects on clustering occur dependently or independently of the actin cytoskeleton. This data is included in Supplementary Figure 6 and discussed in Supplementary material. Supplementary Figure 6 suggests that focal adhesion partners of ILK are not required for centrosome clustering and that ILK is controlling centrosome clustering independently of the actin cytoskeleton. We, therefore, hypothesized that ILK may be influencing centrosome clustering by its microtubule-regulating partner TACC3. To test this we simultaneously perturbed both ILK and TACC3. Figure 4e shows that adding QLT-0267 in addition to TACC3 siRNA does not cause a further increase in the percentage of mitotic cells displaying de-clustered centrosomes when compared with the effect of TACC3 siRNA alone. However, addition of QLT-0267 to Parvin/PINCH siRNA or Mig-2 siRNA does result in an additive effect on centrosome clustering. This suggests ILK is acting through TACC3 and hence, the microtubule cytoskeleton. It has previously been shown that ILK co-localizes with TACC3 at the centrosome . To verify that this was the case in the cell types studied here, BT549 cells were stained for ILK and pericentrin or TACC3, as well as IgG controls (Supplementary Figure 3) . This confirmed that ILK localizes to the centrosome in BT549 cells where it has overlapping localization with TACC3. It is known that ILK perturbation leads to a loss of complex formation between TACC3, Aurora-A and ch-TOG . However, the precise effect that ILK has on these proteins has not been elucidated.
ILK regulates centrosome clustering in concert with its centrosomal partner TACC3
TACC3 phosphorylation is required for centrosome clustering TACC3's microtubule-regulating functions at the centrosome are dependent on its phosphorylation on a conserved serine residue, Ser558 in humans/Ser347 in mice (Giet et al., 2002; Barros et al., 2005; Kinoshita et al., 2005; Peset et al., 2005; LeRoy et al., 2007) . As both spindle and astral microtubules are required to prevent multipolar spindle formation (Kwon et al., 2008) , we investigated whether TACC3 phosphorylation was required for centrosome clustering. A siRNAresistance approach was used, whereby endogenous (human), TACC3 was depleted by siRNA and mouse TACC3 WT or TACC3 serine 347 to alanine mutant (S347A), which were resistant to the siRNA, were expressed. Immunofluorescence analysis indicated that the TACC3 S347A mutant showed markedly reduced localization to the mitotic spindle and spindle poles (Supplementary Figure 7) , in agreement with previous studies that have shown the importance of this phosphorylation event for spindle and centrosome localization of TACC3 Peset et al., 2005; LeRoy et al., 2007) . The effects of expressing these constructs against the background of endogenous TACC3 depletion were then assessed. Figure 5 shows that, although the expression of mTACC3-WT can rescue the effects on centrosome clustering caused by endogenous TACC3 depletion, a mTACC3-S347A construct cannot, indicating the essential nature of this phosphorylation site for successful centrosome clustering.
ILK Perturbation leads to decreased TACC3 phosphorylation
We tested whether ILK inhibition or knockdown affected the phosphorylation of the conserved TACC3 serine residue using a phospho-specific antibody raised against this site. As previously reported, phospho Ser558 TACC3 localized exclusively to centrosomes . This was the case in both bipolar (Figure 6a , upper panel) and multipolar (Figure 6b , upper panel) mitotic spindles. Upon ILK inhibition, this phosphorylation was reduced (Figures 6a and b, lower  panels) . The phosphoSer558 TACC3 signal at centrosomes was quantified from Z-stacks of mitotic cells and this indicated a significantly lower amount of phosphorylation upon ILK inhibition (Figure 6c) . Quantification of cells stained with pericentrin showed that the effect was specific for pTACC3 and not due to a general defect in pericentriolar material recruitment (Supplementary Figure 5) . Total cellular TACC3 (and Aurora-A and ch-TOG) levels were also unaffected (Figures 6d and e) . ILK knockdown by siRNA produced comparable effects on TACC3 phosphorylation (Figure 6f ). It is not clear why total TACC-3 levels are increased in the ILK siRNA knockdown cells (Figure 6g) . However, the significant decrease in phosphorylated TACC-3, despite an increase in total TACC-3 implies a marked effect of depleting ILK on the phosphorylation status of TACC-3, agreeing with the effects of inhibiting ILK activity with QLT-0267. For unknown reasons the phospho-TACC3 antibody did not detect a band in western blots and, therefore, we could not test for the global effects on pTACC levels induced by ILK depletion or inactivation. However, the quantitative immunofluorescence data clearly show that pTACC3 levels are reduced at the centrosome, the functional site of pTACC3 and we are, therefore, confident that the reduction in levels observed will have functional consequences for mitotic spindle organization.
ILK regulates TACC3 phosphorylation in an aurora-A-dependent manner Next, we investigated if the TACC3 Ser558 phosphorylation was a direct consequence of ILK kinase activity or not. This site has been identified as a phosphorylation site for Aurora-A kinase (Giet et al., 2002; Tien et al., 2004; Barros et al., 2005; Kinoshita et al., 2005; LeRoy et al., 2007) . Also, we have shown that ILK depletion or inactivation can effect Aurora-A-TACC3 interactions (Fielding et al., 2008) and the residues surrounding Figure 4 . Upon expression of a WT mouse TACC3 construct, which is resistant to the TACC3siRNA, the de-clustering caused by the TACC3 knockdown is largely rescued (third bar). However, re-expression of mouse TACC3 in which Ser347 (homologous to the Ser588 in human TACC3) is mutated to alanine cannot rescue the knockdown of endogenous TACC3 (fourth bar), indicating this phosphorylation site is required for centrosome clustering. *Po0.05 as determined by Student's t-test.
Ser558 do not show a strong similarity to other known ILK phosphorylation sites (Hannigan et al., 2005) . Therefore, we hypothesized that ILK was likely to be acting upstream of Aurora-A to affect TACC3 phosphorylation. To test this, we overexpressed Aurora-A under conditions of ILK depletion to see whether this could rescue TACC3 phosphorylation. Figure 7 shows that the overexpression of Aurora-A in cells containing normal amounts of ILK causes a small, but insignificant, increase in TACC3 phosphorylation. ILK depletion by siRNA caused a significant reduction in TACC3 phosphorylation (as shown in Figure 6 ). Upon overexpression of Aurora-A in these cells, the TACC3 phosphorylation was rescued back to control levels (Figures 7a and c) , thus indicating that Ser558TACC3 phosphorylation is regulated by ILK in an Aurora-A- dependent manner. Upon measuring the effect on centrosome clustering in these cells it was apparent that the overexpression of Aurora-A also rescued the centrosome de-clustering caused by ILK depletion (Figure 7b) . These results provide a direct mechanistic link between ILK perturbation and the observed defects on centrosome clustering.
Discussion
Centrosome clustering is an essential mechanism for the survival of cancer cells (Rebacz et al., 2007; Kwon et al., 2008; Ganem et al., 2009) . Mechanisms involving microtubules, the actin cytoskeleton, cellextra-cellular-matrix interactions and the spindle assem- Figure 7 Aurora-A over-expression rescues phosphorylation of TACC3 and centrosome clustering under conditions of ILK depletion. To test whether ILK's effects on TACC3 phosphorylation were Aurora-A dependent, Aurora-A was over-expressed under ILK-knockdown conditions. (a) Bar graph of phospho-Ser558-TACC3 quantification. Cells were treated with control or ILK siRNA and either mock transfected or transfected with an Aurora-A plasmid. Cells were then stained with a mouse monoclonal antibody against Aurora-A (to identify transfected cells) and a rabbit polyclonal antibody against phosphoSer558 of TACC3. Z-stack images of the cells were then acquired and the fluorescence intensity of pTACC3 signal at the centrosomes quantified. The average intensity in mock transfected, control siRNA-treated cells was set as 100% and the other values plotted relative to this. In untransfected cells (dark grey bars), it can be seen that ILK siRNA causes a decrease in the pTACC3 signal. However, upon transfection of Aurora-A, the pTACC3 signal is rescued to control levels. This indicates ILK's effects on TACC3 phosphorylation occur in an Aurora-A-dependent manner. ***Po0.001 as determined by Student's t-test. (b) The percentage of mitotic cells with de-clustered centrosomes was calculated for cells treated with ILK siRNA in both cells expressing only endogenous amounts of Aurora-A and cells overexpressing Aurora-A. In ILK siRNA-treated cells, centrosome de-clustering was apparent in 41.4% of mitotic cells. In ILK siRNA-treated cells that also overexpressed Aurora-A, the number of cells displaying de-clustered centrosomes was significantly reduced, indicating that Aurora-A over-expression rescues the centrosome de-clustering defects induced by ILK depletion, as well as the decrease in phosphorylated TACC3. *Po0.05 as determined by Student's t-test. (c) Immunofluorescence examples of Aurora-A and pTACC3-stained cells. Top panel; in cells expressing only endogenous amounts of Aurora-A, ILK siRNA leads to only a weak pTACC3 signal present at centrosomes. Upon transfection of Aurora-A (bottom panel), pTACC3 amounts at the centrosome are markedly increased. Arrowheads indicate centrosomes/spindle poles where Aurora-A and pTACC co-localize in mitotic cells. Identical microscope settings were used to acquire images shown. (d) Western blot to show successful expression of exogenous Aurora-A. As the transfected Aurora-A is tagged with mcherry, it has a significantly higher molecular weight than the endogenous Aurora-A and can, therefore, be readily distinguished on the western blot.
bly checkpoint are required for successful centrosome clustering (Quintyne et al., 2005; Kwon et al., 2008) . As ILK regulates microtubules, the actin cytoskeleton and cell-extra-cellular-matrix interactions it has been proposed as a good candidate to also regulate centrosome clustering (Xu and Saunders, 2008) .
This study shows that ILK is required for centrosome clustering in both breast and prostate cancer cell lines, as genetic or pharmacological inhibition of ILK leads to an increase in the presence of mitotic cells displaying declustered centrosomes. As supernumerary centrosomes are generally only a feature of cancer cells (Nigg, 2002; Kwon et al., 2008; Zyss and Gergely, 2009 ), we next tested for the potential cancer-cell-specific effects of ILK perturbation. ILK inhibition caused almost complete loss of cell proliferation in the cancer-cell lines containing supernumerary centrosomes, whereas non-malignant breast epithelial lines were unaffected by an equal concentration of the ILK inhibitor. This shows that the inhibition of ILK causes cancer-specific defects in cell survival that reflect its centrosome de-clustering activity. Live cell analysis revealed that ILK inhibition causes a large decrease in successful cell divisions, largely attributable to cells becoming arrested in mitosis for prolonged periods followed by either mitotic exit or cell death. Failed cytokinesis and multipolar cell divisions also occur more frequently in cells treated with the ILK inhibitor. All of these outcomes can be attributed to the centrosome de-clustering activity of the ILK inhibitor as cells that fail to cluster supernumerary centrosomes are known to have extended mitoses (Rebacz et al., 2007; Kwon et al., 2008) , undergo apoptosis during mitotic arrest (Rebacz et al., 2007) , undergo failed cytokinesis (Silkworth et al., 2009 ) and execute multipolar cell divisions (Kwon et al., 2008) . Each of these phenomena will also result in decreased cell proliferation and survival and, therefore, the centrosome de-clustering activity observed upon ILK inhibition can be directly related to the decrease in cell survival observed in the clonogenic assays.
This study illustrates that two centrosomal proteins, TACC3 and ch-TOG, which in concert with Aurora-A, are critical for mitotic spindle formation and organization (Gergely et al., 2003; Cassimeris and Morabito, 2004; Barros et al., 2005; Kinoshita et al., 2005; Barr and Gergely, 2008) are required for centrosome clustering. Further investigation demonstrated that a conserved serine residue on TACC3 was required for centrosome clustering and that ILK was regulating Ser558 TACC3 phosphorylation, in an Aurora-Adependent manner. Disruption of this phosphorylation leads to destabilized spindle and astral microtubules and errors in microtubule attachment to centrosomes (Giet et al., 2002; Barros et al., 2005; Kinoshita et al., 2005; Peset et al., 2005; LeRoy et al., 2007; Albee and Wiese, 2008) . These phenotypes will lead to multipolar spindle formation as both spindle and astral microtubules are required for centrosome clustering (Kwon et al., 2008) .
In summary, this report shows that ILK is required for centrosome clustering in both human breast and prostate cancer cells lines and that ILK performs this function by its microtubule-related functions at the centrosome, specifically by regulating TACC3 phosphorylation. Our data provide further evidence to the theory that disrupting centrosome clustering can selectively inhibit the proliferation of supernumerary centrosome-harboring cancer cells (Rebacz et al., 2007; Kwon et al., 2008; Xu and Saunders, 2008) . In this regard, our results provide an exciting proof of concept for targeting centrosome clustering in cancer cells and pave the way towards a new class of targeted cancer therapies.
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